Consent Requirement Change Could Be Boon For Minimal-Risk Studies
Executive Summary
US FDA has issued a temporary guidance to allow researchers to conduct "minimal-risk" clinical studies without consent and harmonize the agency's policy with the federal Common Rule for human subject research. The guideline implements a provision in the 21st Century Cures Act.